title: Prevalence of amebiasis in inflammatory bowel disease in University Clinical Hospital Mostar.
abstract: OBJECTIVE
  To explore the prevalence of amebiasis in inflammatory bowel disease (IBD), Crohn's disease and ulcerative colitis, in patients in Clinical hospital Mostar (Bosnia and Herzegovina, region of Herzegovina).
  
  
  METHODS
  In this study, Entamoeba histolytica/dispar prevalence was investigated in fresh faeces by native microscopy and immunochromatographic rapid assay "RIDA(®)QUICK Entamoeba test", in 119 cases of new found IBD patients, 84 of ulcerative colitis and 35 of Crohn's disease and in control group who had also 119 patients who didn't have any gastrointestinal complaints. IBD diagnosis was established by standard diagnostic procedures (anamnesis, clinical manifestations, laboratory, endoscopy and biopsy).
  
  
  RESULTS
  Entamoeba histolytica/dispar were found in 19 (16.0 %) of a total of 119 cases, 12 (14.3 %) of the 84 patients with ulcerative colitis and 7 (20.0 %) of the 35 patients with Crohn's disease. As for the 119 patients in the control group who had not any gastrointestinal complaints, 2 (1.7 %) patients were found to have E. histolytica/dispar in their faeces. Amoeba prevalence in the patient group was determined to be significantly higher in group with Crohn's disease, ulcerative colitis and IBD total than in the control group (p < 0.001).
  
  
  CONCLUSIONS
  Ameba infections in patients with Crohn's disease and ulcerative colitis, have a greater prevalence compared to the normal population.
authors.affiliation: Department of Gastroenterology and Hepatology, University of Mostar Clinical Hospital, Bijeli Brijeg bb, 88000 Mostar, Bosnia and Herzegovina.
authors.forename: Emil
authors.identifier: 0000-0002-7271-4980
authors.initials: E
authors.lastname: Babić
authors.affiliation: Department of Gastroenterology and Hepatology, University of Mostar Clinical Hospital, Bijeli Brijeg bb, 88000 Mostar, Bosnia and Herzegovina.
authors.forename: Milenko
authors.initials: M
authors.lastname: Bevanda
authors.affiliation: Department of Gastroenterology and Hepatology, University of Mostar Clinical Hospital, Bijeli Brijeg bb, 88000 Mostar, Bosnia and Herzegovina.
authors.forename: Mladen
authors.initials: M
authors.lastname: Mimica
authors.affiliation: Department of Gastroenterology and Hepatology, University of Mostar Clinical Hospital, Bijeli Brijeg bb, 88000 Mostar, Bosnia and Herzegovina.
authors.forename: Maja
authors.initials: M
authors.lastname: Karin
authors.affiliation: Department of Gastroenterology and Hepatology, University of Mostar Clinical Hospital, Bijeli Brijeg bb, 88000 Mostar, Bosnia and Herzegovina.
authors.forename: Mile
authors.initials: M
authors.lastname: Volarić
authors.affiliation: Department of Gastroenterology and Hepatology, University of Mostar Clinical Hospital, Bijeli Brijeg bb, 88000 Mostar, Bosnia and Herzegovina.
authors.forename: Ante
authors.initials: A
authors.lastname: Bogut
authors.affiliation: Department of Ginecology, University of Mostar Clinical Hospital, Bijeli Brijeg bb, 88000 Mostar, Bosnia and Herzegovina.
authors.forename: Tatjana
authors.initials: T
authors.lastname: Barišić
authors.affiliation: Department of Gastroenterology and Hepatology, University of Mostar Clinical Hospital, Bijeli Brijeg bb, 88000 Mostar, Bosnia and Herzegovina.
authors.forename: Danijel
authors.initials: D
authors.lastname: Pravdić
authors.affiliation: Department of Abdominal Surgery, University of Mostar Clinical Hospital, Bijeli Brijeg bb, 88000 Mostar, Bosnia and Herzegovina.
authors.forename: Nikica
authors.initials: N
authors.lastname: Šutalo
keywords: Amebiasis; Immune response; Inflammation; Inflammatory bowel disease; Prevalence